Prior information notice
This notice is for prior information only
Section I: Contracting
authority
I.1) Name and addresses
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw
Cardiff
CF15 7QZ
UK
Telephone: +44 1443848585
E-mail: amy.slocombe@wales.nhs.uk
NUTS: UK
Internet address(es)
Main address: http://nwssp.nhs.wales/ourservices/procurement-services/
Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.3) Communication
Additional information can be obtained from the abovementioned address
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
GRIDION™ MK1 OXFORD NANPORE CAPITAL PURCHASE
Reference number: CAV-DCO (21-22) 264
II.1.2) Main CPV code
33100000
II.1.3) Type of contract
Supplies
II.1.4) Short description
NWSSP on behalf of Cardiff and Value UHB have been requested to purchase a GRIDION™ MK1 from Oxford Nanopore Technologies. Oxford Nanopore is listed as a supplier on Public Health England National Microbiology Framework Lot 1. The framework allows for direct award on technical justification. Further details within the main description of this notice
II.1.5) Estimated total value
Value excluding VAT:
107 125.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
UKL22
II.2.4) Description of the procurement
This notice is to confirm a contract will be placed with Oxford Nanopore Technologies for the purchase of the GridION™ Mk1. The contract will be direct awarded on technical grounds via Public Health England National Microbiology Framework Lot 1. This notice is to be taken as the 10 day standstill period and will expire on the 11th March at midnight. If you have any questions regarding this notice please contact us through sell to wales.
Patents held by Oxford Nanopore Technologies in Europe and the United States, GridION Mk1 cannot be offered by other companies.
The equipment has the below unique features: -
- 5 asynchronous sequencing ports allowing flexibility for sequencing runs.
- Compatible with both MinION and Flongle flow cells, providing the option to go for a low or higher throughput sequencing run
- A benchtop instrument with built in GPU capacity for real-time basecalling and analysis
- Adaptive sampling capability, allowing for customisable computational target enrichment, with the same workflow
- Nanopore sequencing has unrestricted read length, allowing for both short and long reads to be generated on the platform
Exclusivity for component used in Nanopore Detection Technology provided by Oxford Nanopore Technologies, as well as for methods performed by the same technology, is considered exclusive to the company and is protected by one or more of the following patents, owned or exclusively licensed to the company:
- WO2010/086622 - US5795782A1
- WO2012/164270 - US6015714A1
- WO2013/014451 - US6362002B1
- WO2014/013260 - EP1238275B1
- WO2013/041878 - US8673556B2
- WO2010/000789
II.2.14) Additional information
This notice is to be taken as the 10 day standstill period and will expire on the 11th March at midnight.
II.3) Estimated date of publication of contract notice:
11/03/2022
Section IV: Procedure
IV.1) Description
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section VI: Complementary information
VI.3) Additional information
This notice is to be taken as the 10 day standstill period and will expire on the 11th March at midnight.
NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at http://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=119073.
(WA Ref:119073)
VI.5) Date of dispatch of this notice
28/02/2022